CN108130385A - A kind of human cytomegalovirus kit for detecting nucleic acid - Google Patents

A kind of human cytomegalovirus kit for detecting nucleic acid Download PDF

Info

Publication number
CN108130385A
CN108130385A CN201711447814.XA CN201711447814A CN108130385A CN 108130385 A CN108130385 A CN 108130385A CN 201711447814 A CN201711447814 A CN 201711447814A CN 108130385 A CN108130385 A CN 108130385A
Authority
CN
China
Prior art keywords
kit
seq
nucleic acid
fluorescence
human cytomegalovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711447814.XA
Other languages
Chinese (zh)
Inventor
吴大治
夏懿
吴梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Xingyao Medical Technology Development Co Ltd
Original Assignee
Shanghai Xingyao Medical Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Xingyao Medical Technology Development Co Ltd filed Critical Shanghai Xingyao Medical Technology Development Co Ltd
Priority to CN201711447814.XA priority Critical patent/CN108130385A/en
Publication of CN108130385A publication Critical patent/CN108130385A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a kind of kits of highly sensitive detection human cytomegalovirus nucleic acid.It expands the viral specific nucleic acids sequence using pair of primers, and passes through two fluorescence probe detection human cytomegalovirus nucleic acid, human cytomegalovirus nucleic acid in the highly sensitive qualitative or quantitative detection whole blood of energy, blood plasma, urine, milk sample.Kit is easy to operate quickly, testing result is sensitive and accurate, can be as effective auxiliary detection means of human cytomegalovirus infection.

Description

A kind of human cytomegalovirus kit for detecting nucleic acid
Technical field
The present invention relates to a kind of human cytomegalovirus nucleic acid fluorescent PCR detection kits, belong to biotechnology.
Background technology
Human cytomegalovirus(Human Cytomegalic Virus, HCMV) belong to herpetoviridae, it is human herpes Maximum a kind of virus in viral group, diameter 200nm, core are bifilar linear DNA, there is typical herpesviral structure.HCMV It can only be proliferated, and cannot be grown in other zooblasts in people's fibroblast culture, proliferation is very slow, first to detach Cellular pathogenic effect (CPE) could occur in 1 wheat harvesting period of need, lead to cell rounding, expand, cell and core gigantism, around core There is large-scale eosinophilic inclusion, thus also known as cytomegalic inclusion disease (Cytomegalic inclusion disease, CID).People's HCMV infection is a kind of systemic infection syndrome, is clinically involved for multi viscera, and complicated symptoms are various, most For subclinical infection, the retinitis, hepatitis, pneumonia, encephalitis, colitis, monocytosis,mononucleosis, decrease of platelet can occur for minority The multiple organs lesions such as property purpura.HCMV infection is very universal, and in worldwide prevalence, infection rate is very high in crowd, flourishing and hair National infection rate is respectively 45~50% and more than 90% in exhibition.HCMV viruses can hide in vivo for a long time, once immunity of organisms Decline, virus will be activated and cause a disease, and particularly to leukaemia, immunosuppressive patient, latent herpesviral activates to be formed Recurrent infection causes transplant organ necrosis and endangers patients ' lives, threatens human health when serious.Further, since giant cell is sick Poison can cause stillborn foetus, miscarriage, premature labor through intrauterine infection, may also lead to congenital malformation, thus HCMV infection can also influence aristogenesis Good child-rearing and quality of the people.
Clinical labororatory's HCMV infection detection generally uses the culture of goldstandard virus purification, serology and detection of nucleic acids side Method, and respectively have advantage and disadvantage.Since HCMV growth cycles are long(30 days), virus purification cultivation be not suitable for clinical labororatory use. Serologic detection detects viral associated proteins using antigen-antibody reaction, has the advantages that detection is quick, simple, easily operated, But detection sensitivity is not high, and since antibody generates " window phase " after infection, also there are certain hysteresis qualitys for detection.Detection of nucleic acids skill In art, particularly fluorescence PCR method have many advantages, such as specificity and high sensitivity, can quantify, is easy to operate, cost it is relatively low, energy The presence of HCMV nucleic acid in detection whole blood, blood plasma, serum, urine and milk equal samples, as HCMV infection detection Auxiliary tool promotes and applies.
The present invention is based on above-mentioned technical backgrounds, it is therefore an objective to the highly sensitive detection human cytomegalovirus-specific primer of design screening Probe develops HCMV nucleic acid fluorescent PCR kits, can realize the qualitative or quantitative detection of high sensitivity of HCMV viral nucleic acids, be The auxiliary diagnosis of clinical HCMV infection or treatment provide foundation.
Invention content
The present invention provides a kind of fluorescent PCR kit of highly sensitive detection human cytomegalovirus nucleic acid, which is characterized in that institute Kit is stated using a pair of of human cytomegalovirus amplimer and two fluorescence probes, pair of primers has SEQ ID NO:1 He SEQ ID NO:2 sequence, two Fluorescence Fluorescence probes have SEQ ID NO:3 and SEQ ID NO:4 sequences and fluorescence probe 5 ' ends mark identical fluorescein or fluorescent dye reporter group, 3 ' end mark fluorescent quenching groups.Kit uses SEQ ID NO:1~4 primer and fluorescence probe are aided with the fluorescence of Tris-HCl, KCl, dNTPs, Taq archaeal dna polymerase and UNG enzymes composition PCR reaction systems, can highly sensitive qualitative or quantitative detection whole blood, blood plasma, urine, human cytomegalovirus nucleic acid in milk sample. Kit is easy to operate quickly, testing result is sensitive and accurate, can be as effective auxiliary detection means of human cytomegalovirus infection.
Technical solution
By to human cytomegalovirus gene sequence queries in GenBank, with molecular biology primed probe design software to each Design is compared in the gene order in kind of source, and according to the principle that TaqMan fluorescent PCRs design, preferably a pair of of HCMV is specific It is highly conserved in upstream and downstream primer amplification viral genome can early gene(IE2)Middle UL122 regions 139bp segment target sequences, two that on detection target sequence location non-overlapping copies or complementation are devised between upstream and downstream primer are glimmering Light probe A, B, wherein fluorescence probe A and the complementation of target sequence antisense strand, fluorescence probe B and target sequence positive-sense strand are complementary, therefore one Secondary PCR cycle reaction can generate 2 fluorescent moleculars, substantially increase detection sensitivity.4 primer and probe nucleotide sequences (5’ -> 3’)It is as follows.
Sense primer:AgAgAgCgATTggTgTTgCg, sequence are denoted as SEQ ID NO:1.
Downstream primer:CCgAgTTggACAACgAgAAgg, sequence are denoted as SEQ ID NO:2.
Fluorescence probe A:ATgCggCTCACCTCgTCAATCTTg, sequence are denoted as SEQ ID NO:3, middle probe 5 ' is held Flag F AM(6-carboxy-fluorescein)Fluorescent reporter group, 3 ' end label BHQ(Black hole quencher)It quenches Go out group.
Fluorescence probe B:AAgAACACCCCCTTCTgCACACCC, sequence are denoted as SEQ ID NO:4, middle probe 5 ' is held Flag F AM fluorescent reporter groups, 3 ' end label BHQ quenching groups.
Two end of fluorescence probe 5 ' requirements mark identical fluorescein or fluorescent dye reporter group, in addition to FAM fluorescent bases Group, can also select JOE(carboxy-dichloro-dimethoxyfluorescein)、VIC、HEX(carboxy- hexachloro-fluorescein)、ROX(5-Carboxy-X-rhodamine)、Cy3(Cyanine 3)、Cy5(Cyanine 5)Fluorophors are waited, 3 ' ends can also select TAMRA in addition to marking BHQ quenching groups(Carboxy-tetra-methyl- rhodamine)Wait quenching groups.
Between present invention design HCMV pair of primers, there is very close Tm values, and fluorescence between two fluorescence probes Probe Tm values are higher than 5~10 DEG C of primer Tm, without apparent primer dimer or hairpin structure between primer probe sequence, protect The specificity and high efficiency of amplification have been demonstrate,proved, has been conducive to improve kit detection sensitivity.
The amplification reaction system is respectively as follows into being grouped as:10mM Tris-HCl(pH8.3), 50mM KCl, 0.2~ 0.5mM dNTPs, 1.5~5 mM MgCl2, each 0.1~0.5 μM of primer and fluorescence probe(SEQ ID NO:1~4), 1~5 U Taq archaeal dna polymerases and 0.01~1 U UNG enzymes, the 10 μ l of template of extraction, 30 μ l of total reaction volume.More specifically, amplification is anti- Answer each ingredient of liquid final concentration of:Tris-HCl(pH8.3)10 mM, KCl 50 mM, dATP, dGTP, dCTP, dUTP each 0.2 MM, MgCl23.5 mM, pair of primers(SEQ ID NO:3 and SEQ ID NO:4)Each 0.3 μM, two fluorescence probes(SEQ ID NO:3 and SEQ ID NO:4)Each 0.2 μM, 2 U of Taq archaeal dna polymerases, 0.5 U of UNG enzymes.
The HCMV kit for detecting nucleic acid is as follows using amplification program:According to 94 DEG C after 50 DEG C of 2min, 94 DEG C of 5min 10sec, 60 DEG C of 45sec cyclic amplifications 45 times acquire FAM channel wavelength fluorescence signals at 60 DEG C in circulation step.
It is linear that the quality-control product of the HCMV kit for detecting nucleic acid includes 1 negative control, 1 positive control and 4 The viral nucleic acid quantitative calibration product of gradient concentration, 4 calibration object HCMV nucleic acid concentrations are respectively 5.0x107 copies/ml、 5.0x106 copies/ml、5.0x105 copies/ml、5.0x104Copies/ml, calibration object is contains SEQ ID NO:1 The TA cloned plasmids of~2 amplification target sequences.Positive control is the Escherichia coli containing the cloned plasmids.
The HCMV kit for detecting nucleic acid, using the viral DNA extracts reagent based on paramagnetic particle method nucleic acid extraction, in nucleic acid Sample nucleic acid automation extraction is realized on extraction apparatus.
A pair of of the HCMV primers and two fluorescence probes preferably obtained by above-mentioned design is aided with Fluorescence PCR its Its component and kit reagent box, the present invention provides the kits of real-time fluorescence quantitative PCR detection, optimize PCR reactions System and amplification program.Certain this research field technical staff can adjust PCR reaction systems according to the general requirement of fluorescent PCR And program, also the same purpose that can realize detection.
Advantageous effect
The present invention is grown up according to the primed probe and technical solution of above-mentioned design by optimizing reaction system and amplification condition development Cytomegalovirus nucleic acid fluorescent PCR immue quantitative detection reagent boxes, main feature are as follows:
(1)Based on improved TaqMan probe Fluorescence PCR assay, two and amplification target sequence are devised between one couple of PCR primers Column position non-overlapping copies or the fluorescence probe of complementation breach traditional TaqMan probe fluorescent PCR one cycle reaction and generate one The limitation of a fluorescent molecular, each PCR cycle of target sequence DNA molecular can generate two fluorescent moleculars, substantially increase examination Agent box detects HCMV nucleic acid sensitivity.
(2)Tm values approach and without secondary structure is intersected, ensure that virus between the HCMV primers of design, between fluorescence probe The specificity and high efficiency of amplification are conducive to improve the sensitivity of kit detection HCMV nucleic acid.
(3)Result false positive caused by dUTP-UNG enzyme systems in amplification system can avoid gene-amplification product pollution, Improve the accuracy of kit testing result.
(4)Kit extracts sample nucleic acid, suitable for whole blood, blood plasma, serum, urine, milk using paramagnetic particle method automation Equal samples type, extraction detection is easy to operate quick, can report testing result in 2 hours, improve work efficiency.
The These characteristics of kit are HCMV primed probes using specific designs and are combined with Fluorescence PCR assay Using and directly cause.From the principle, kit of the present invention HCMV clinical samples detection in by expanding real-time fluorescence PCR Increase the analysis of fluorescence signal, judge presence and the virus load of viral nucleic acid specific fragment, technical scheme of the present invention design Rationally, the highly sensitive qualitative or quantitative detection of human cytomegalovirus is can be widely applied to, it can be as the effective auxiliary of HCMV infection Help detection means.
Specific embodiment
With reference to specific embodiment, the present invention is further explained.It should be understood that these embodiments are merely to illustrate the present invention Rather than it limits the scope of the invention.In addition, it should also be understood that, after reading the content taught by the present invention, people in the art Member can make the present invention by common technical knowledge various technical changes or modification, and such equivalent forms equally fall within the application institute Attached claims limited range.
Embodiment 1:Human cytomegalovirus kit for detecting nucleic acid primed probe designs
It is excellent using molecular biology primer-design software according to the HCMV gene orders inquired in NCBI GenBank databases The primer probe sequence for selecting acquisition is as shown in table 1, and HCMV primer amplifications are 139bp segments on virus IE2 genes.
The kit primed probe that table 1 designs
The synthesis of more than primed probe commission Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.
Embodiment 2:Human cytomegalovirus kit for detecting nucleic acid is prepared
Kit reaction buffer prepares 32 person-portion kits reaction buffering voluntarily to prepare, by 2 each component concentration of table and volume Liquid, it is 20 μ l that the reaction buffer of preparation, which each reacts packing dosage, and total reaction volume is 30 μ l after adding in 10 μ l of template.
2 kit reaction buffer of table prepares each group partial volume
Kit negative control uses normal person's negative plasma;Quantitative calibration product are the clone that target sequence segment is expanded containing HCMV Plasmid is diluted to 4 concentration as kit quantification calibration object by the use of TE buffer solutions:5.0x107 copies/ml、5.0x106 copies/ml、5.0x105 copies/ml、5.0x104copies/ml;Positive control is the large intestine containing above-mentioned cloned plasmids Bacillus, employment negative plasma are diluted to a concentration of 5.0x103 copies/ml。
The paramagnetic particle method virus that kit viral DNA extracts reagent is developed using Shanghai Xingyao Medical Technology Development Co., Ltd. DNA extraction kit, it includes 5 magnetic bead, lysate, Proteinase K, cleaning buffer solution, elution buffer components, and when use tries Agent box negative control, positive control, sample extract nucleic acid using the kit.
Kit amplification program is:Expand after 50 DEG C of 2min, 94 DEG C of 5min according to 94 DEG C of 10sec, 60 DEG C of 45sec cycles Increase 45 times, acquire FAM channel wavelength fluorescence signals in circulation step at 60 DEG C.
Included by the HCMV kit for detecting nucleic acid components of above-mentioned preparation:Reaction buffer, negative control, positive control And 4 quantitative calibration product, it is desirable that -20 DEG C of storage and transport.
Embodiment 3:The measure of kit detection sensitivity
(1)Viral DNA extracts
It learns from else's experience clinical identification, HCMV positive blood plasma known to concentration, HCMV concentration is 2x10 in sample5copies/ml).So Normal person's negative plasma is used afterwards by 10 times of continuous gradient dilutions of the mixing sample to 2x104 copies/ml、2x103 copies/ml、2x102 copies/ml、2x101Copies/ml draws above-mentioned viral dilution, kit negative control, sun Property each 400 μ l of control, the paramagnetic particle method viral DNA extracts reagent being used together in embodiment 2 carries out virus on instrument for extracting nucleic acid DNA is extracted, each 50 μ l of nucleic acid that last each sample obtains.
(2)Fluorescent PCR detects
Kit reaction buffer in embodiment 2 is taken out into freeze thawing, mixing, of short duration centrifugation from -20 DEG C of refrigerators, by 20 μ l/ person-portions Reaction buffer is dispensed into PCR reaction tubes, be then respectively adding the kit negative control of said extracted, positive control, The template of viral dilution extraction and each 10 μ l of quantitative calibration product without nucleic acid extraction.Each reaction pipe volume is 30 μ Above-mentioned reaction tube is put on ABI7500 fluorescent PCR instrument by l, is set each reaction tube sample type and is set quantitative calibration product dense Angle value reacts 2 minutes according to 50 DEG C, then keeps the temperature 5 minutes for 94 DEG C, then recycled 45 times within 45 seconds by 94 DEG C 10 seconds → 60 DEG C( 60 DEG C of acquisition FAM channel wavelength fluorescence signals)Response procedures operation.According to instrument software and kit explanation after amplification Book analyzes and determines experimental result.
(3)Interpretation of result
Kit negative control testing result is negative for HCMV, and positive control testing result is positive for HCMV, in FAM channels by dense Angle value sets HCMV quantitative calibration product magnitudes, and calibration object detection linearly dependent coefficient is all higher than 0.98, Pass Test Quality Control requirement. Observe 2x104 copies/ml、2x103 copies/ml、2x102 copies/ml、2x101The sample of copies/ml concentration Product gradient is repeated 5 times detection respectively, and HCMV results are the positive, thus may determine that kit is sensitive to the detection of HCMV nucleic acid Degree can reach 2x101Copies/ml can realize the highly sensitive qualitative or quantitative detection of HCMV nucleic acid.
Embodiment 4:Application of the kit in people's CID patient's sample HCMV detections
(1)Viral DNA extracts
Take clinical 25, the HCMV infection sample collected(Each 5 of whole blood, blood plasma, serum, urine, milk sample)、Epstein- Barr viruses infect whole blood sample 5, and the paramagnetic particle method disease in embodiment 2 is used together with kit negative control, positive control Malicious DNA extracts reagents carry out viral DNA extraction on instrument for extracting nucleic acid, and each 400 μ l of sample volume obtain core after extraction Each 50 μ l of acid.
(2)Fluorescent PCR testing result
Kit in embodiment 2 is expanded into part(Reaction buffer)Freeze thawing, mixing, of short duration centrifugation are taken out from -20 DEG C of refrigerators, is pressed Reaction buffer is dispensed into PCR reaction tubes by 20 μ l/ person-portions, be then respectively adding said extracted kit negative control, Positive control, the template of sample extraction and each 10 μ l of quantitative calibration product without nucleic acid extraction.Each reaction pipe volume is Above-mentioned reaction tube is put on ABI7500 fluorescent PCR instrument by 30 μ l, is set each reaction tube sample type and is set quantitative calibration Product concentration value reacts 2 minutes according to 50 DEG C, then keeps the temperature 5 minutes for 94 DEG C, then recycled 45 times within 45 seconds by 94 DEG C 10 seconds → 60 DEG C (FAM channel wavelength fluorescence signals are acquired at 60 DEG C)Response procedures operation.According to instrument software and kit after amplification Specification analyzes and determines experimental result, it is known that this 25 samples(Whole blood, blood plasma, serum, urine, milk sample each 2)It is HCMV nucleic acid is positive and 5 Epstein-barr viruses infection whole blood samples are negative for HCMV, and it is various to illustrate that kit is suitable for The detection of HCMV in type sample, accuracy and specificity are good.
Sequence table
<110>Shanghai Xingyao Medical Technology Development Co., Ltd.
<120>A kind of human cytomegalovirus kit for detecting nucleic acid
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 20
<212> DNA
<213>Artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(20)
<223>Sense primer
<400> 1
agagagcgat tggtgttgcg 20
<210> 2
<211> 21
<212> DNA
<213>Artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(21)
<223>Downstream primer
<400> 2
ccgagttgga caacgagaag g 21
<210> 3
<211> 26
<212> DNA
<213>Artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(26)
<223>Fluorescence probe A; b=FAM; d=BHQ
<400> 3
batgcggctc acctcgtcaa tcttgd 26
<210> 4
<211> 26
<212> DNA
<213>Artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(26)
<223>Fluorescence probe B; b=FAM; d=BHQ
<400> 4
baagaacacc cccttctgca cacccd 26

Claims (6)

  1. A kind of 1. kit based on the highly sensitive detection human cytomegalovirus nucleic acid of Fluorescence PCR assay, which is characterized in that the examination Agent box has SEQ ID NO using a pair of of human cytomegalovirus amplimer and two fluorescence probes, pair of primers:1 and SEQ ID NO:2 sequence, two fluorescence probes have SEQ ID NO:3 and SEQ ID NO:4 sequences and the end of fluorescence probe 5 ' label Identical fluorescein or fluorescent dye reporter group, 3 ' end mark fluorescent quenching groups.
  2. 2. kit as described in claim 1, which is characterized in that the fluorescein or fluorescent dye reporter group are FAM Fluorophor or it is other it is any can as probe mark fluorescein or fluorescent dye, the fluorescent quenching group for BHQ, TAMRA or other is any can be as the compound of quenching group.
  3. 3. kit as described in claim 1, which is characterized in that the kit reaction system is respectively as follows into being grouped as: Tris-HCl, 50mM KCl, 0.2~0.5mM dNTPs, 1.5~5 mM MgCl of 10mM pH8.32, it is 0.1~0.5 μM each SEQ ID NO:1~4 primer and fluorescence probe, 1~5 U Taq archaeal dna polymerases and 0.01~1 U UNG enzymes, the template of extraction 10 μ l, 30 μ l of total reaction volume.
  4. 4. kit as described in claim 1, which is characterized in that each ingredient of kit reaction solution is final concentration of: Tris-HCl 10 mM, KCl 50 mM, dATP, dGTP, dCTP, dUTP each 0.2 mM, MgCl of pH8.323.5 mM, SEQ ID NO:1 and SEQ ID NO:Each 0.3 μM of 2 primers, SEQ ID NO:3 and SEQ ID NO:Each 0.2 μM of 4 fluorescence probes, Taq 2 U of archaeal dna polymerase, 0.5 U of UNG enzymes.
  5. 5. kit as described in claim 1, the amplification program used is as follows:According to 94 after 50 DEG C of 2min, 94 DEG C of 5min DEG C 10sec, 60 DEG C of 45sec cyclic amplifications 45 times acquire fluorescent reporter group launch wavelength fluorescence in 60 DEG C of each cycle Signal.
  6. 6. kit as described in claim 1, including negative control, positive control and viral nucleic acid quantitative calibration product.
CN201711447814.XA 2017-12-27 2017-12-27 A kind of human cytomegalovirus kit for detecting nucleic acid Pending CN108130385A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711447814.XA CN108130385A (en) 2017-12-27 2017-12-27 A kind of human cytomegalovirus kit for detecting nucleic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711447814.XA CN108130385A (en) 2017-12-27 2017-12-27 A kind of human cytomegalovirus kit for detecting nucleic acid

Publications (1)

Publication Number Publication Date
CN108130385A true CN108130385A (en) 2018-06-08

Family

ID=62393436

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711447814.XA Pending CN108130385A (en) 2017-12-27 2017-12-27 A kind of human cytomegalovirus kit for detecting nucleic acid

Country Status (1)

Country Link
CN (1) CN108130385A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022620A (en) * 2018-08-27 2018-12-18 郑州安图生物工程股份有限公司 It is a kind of for detecting the kit of human cytomegalovirus
CN111500779A (en) * 2020-05-06 2020-08-07 深圳康美生物科技股份有限公司 Kit for detecting human cytomegalovirus based on fluorescence PCR or mass spectrum
CN115044688A (en) * 2022-06-22 2022-09-13 江苏康为世纪生物科技股份有限公司 Freeze-dried PCR reagent and kit for helicobacter pylori nucleic acid detection

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004023091A2 (en) * 2002-09-03 2004-03-18 The Uab Research Foundation Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells
CN101760560A (en) * 2008-10-23 2010-06-30 上海复星医药(集团)股份有限公司 Fluorescent PCR detection method for human cytomegalovirus (HCMV)
CN102115794A (en) * 2009-12-30 2011-07-06 上海复星医学科技发展有限公司 Internal-reference-containing HCMV fluorescence quantitative PCR detection kit
CN102260748A (en) * 2010-05-26 2011-11-30 浙江省血液中心 Method for detecting human cytomegalovirus by loop-mediated isothermal amplification, kit for detection and primer group
CN103805713A (en) * 2014-01-08 2014-05-21 厦门安普利生物工程有限公司 Human cytomegalovirus nucleic acid quantitative detection primer and probe, kit and application thereof
CN105136782A (en) * 2015-09-15 2015-12-09 安徽博睿生物科技有限公司 Immune magnetic micro-particle chemiluminescence method HCMV IE1 antigen detection kit
CN106676198A (en) * 2016-12-30 2017-05-17 上海星耀医学科技发展有限公司 High-sensitivity quantitative detection kit for herpes virus 4 and herpes virus 5

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004023091A2 (en) * 2002-09-03 2004-03-18 The Uab Research Foundation Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells
CN101760560A (en) * 2008-10-23 2010-06-30 上海复星医药(集团)股份有限公司 Fluorescent PCR detection method for human cytomegalovirus (HCMV)
CN102115794A (en) * 2009-12-30 2011-07-06 上海复星医学科技发展有限公司 Internal-reference-containing HCMV fluorescence quantitative PCR detection kit
CN102260748A (en) * 2010-05-26 2011-11-30 浙江省血液中心 Method for detecting human cytomegalovirus by loop-mediated isothermal amplification, kit for detection and primer group
CN103805713A (en) * 2014-01-08 2014-05-21 厦门安普利生物工程有限公司 Human cytomegalovirus nucleic acid quantitative detection primer and probe, kit and application thereof
CN105136782A (en) * 2015-09-15 2015-12-09 安徽博睿生物科技有限公司 Immune magnetic micro-particle chemiluminescence method HCMV IE1 antigen detection kit
CN106676198A (en) * 2016-12-30 2017-05-17 上海星耀医学科技发展有限公司 High-sensitivity quantitative detection kit for herpes virus 4 and herpes virus 5

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
卢元元,方峰: "人巨细胞病毒IE蛋白功能的研究进展", 《中华实验和临床病毒学杂》 *
崔之础,张冬雷,施健等: "荧光定量两探针法检测HCV RNA的研究", 《临床检验杂志》 *
张菊,向稚丹,刘兴楼等: "大蒜新素对人巨细胞病毒即刻早期、早期和晚期基因转录水平的影响", 《中国中药杂志》 *
陈琳,万艳平: "人巨细胞病毒IE1蛋白功能研究进展", 《微生物学免疫学进展》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022620A (en) * 2018-08-27 2018-12-18 郑州安图生物工程股份有限公司 It is a kind of for detecting the kit of human cytomegalovirus
CN111500779A (en) * 2020-05-06 2020-08-07 深圳康美生物科技股份有限公司 Kit for detecting human cytomegalovirus based on fluorescence PCR or mass spectrum
CN115044688A (en) * 2022-06-22 2022-09-13 江苏康为世纪生物科技股份有限公司 Freeze-dried PCR reagent and kit for helicobacter pylori nucleic acid detection

Similar Documents

Publication Publication Date Title
CN106399590B (en) Universal nucleic acid isothermal detection reagent for respiratory tract infection related adenovirus
CN112538550B (en) RT-RPA and CRISPR/Cas-based DHAV-1 and DHAV-3 detection system and application
CN113528709B (en) Fluorescent quantitative PCR detection method capable of covering 13-type adenovirus and kit
WO2010102460A1 (en) A method and kit for quantitative and qualitative detection of genetic material of pathogenic microorganisms
CN110055353B (en) Internal reference-containing double isothermal nucleic acid amplification method for rapidly detecting 7-type adenovirus
CN104046704A (en) Dual fluorescence quantitative method for quickly identifying type 1 and type 3 duck hepatitis A viruses
CN111286559B (en) Primer, probe and kit for detecting African swine fever virus
CN103397105B (en) Kit for detecting GII type norovirus and applications thereof
CN103642945A (en) Reference-containing high-sensitivity fluorescent quantitative polymerase chain reaction (PCR) kit for Epstein-Barr virus
CN109504803A (en) A kind of RPA method, its primer special and probe and purposes detecting 7 type adenovirus hominis
CN110106285A (en) A kind of dual isothermal nucleic acid amplification method containing internal reference of 3 type adenovirus hominis of quick detection
CN108130385A (en) A kind of human cytomegalovirus kit for detecting nucleic acid
CN105624329A (en) Real-time fluorescence nucleic acid isothermal amplification detection kit for human herpesvirus 1
CN106676198A (en) High-sensitivity quantitative detection kit for herpes virus 4 and herpes virus 5
CN105779644B (en) The real-time fluorescence nucleic acid isothermal amplification detection kit of human cytomegalovirus
CN113652505A (en) Method and kit for detecting novel coronavirus and VOC-202012/01 mutant strain thereof
CN114015815B (en) Microdroplet digital PCR kit for swine atypical pestivirus and detection method thereof
Gou et al. The colorimetric isothermal multiple-self-matching-initiated amplification using cresol red for rapid and sensitive detection of porcine circovirus 3
CN102251061A (en) Nucleic acid dual fluorescence PCR (Polymerase Chain Reaction) detection kit for influenza A/B virus
CN114540526A (en) Primer, probe and method for typing detection of five input plasmodium
AU2020104141A4 (en) A primer and probe composition, a kit and application for rpa detection of newcastle disease virus
Xia et al. Rapid detection of Banna virus by reverse transcription-loop-mediated isothermal amplification (RT-LAMP)
CN109439801A (en) A kind of honeybee Israel acute paralysis virus real-time fluorescent RT-PCR detection reagent box and its detection method
CN105238880A (en) Enterovirus real-time fluorescent quantitative detection kit
CN104342487B (en) Mycoplasma nucleic acid constant-temperature amplification method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination